开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
Sinus Berlin
Orthopedic oncology faces unique challenges in delivering chemotherapeutic drugs effectively while minimizing
systemic toxicity. Recent advancements in drug delivery systems have propelled the development of innovative carriers
designed to enhance targeted delivery to musculoskeletal tumors. This abstract provides a concise overview of these
advancements, focusing on key modalities such as nanoparticles, polymeric micelles, liposomes, hydrogels, and
magnetic drug delivery. These carriers offer the potential for precise and personalized treatment strategies, allowing
for increased drug bioavailability at the tumor site while minimizing adverse effects on healthy tissues. The abstract
underscores the transformative impact of these advancements on the future of orthopedic oncology, emphasizing the
potential for improved therapeutic outcomes and reduced treatment-related morbidity.